LB Pharmaceuticals grants inducement options to new CMO and CFO
LB Pharmaceuticals granted inducement options to its new CMO and CFO for 200,000 shares at $37.22 each, vesting over four years under Nasdaq Rule 5635(c)(4).
LB Pharmaceuticals granted inducement options to its new CMO and CFO for 200,000 shares at $37.22 each, vesting over four years under Nasdaq Rule 5635(c)(4).